The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,843,962 in first-year total cost, median $680,829.
Most frequent study sections
- Special Emphasis Panel[ZRG1 AARR-P (52)]4
Most frequent institutions
- ERASMUS MEDICAL CENTER1
- INSTITUTE OF HUMAN VIROLOGY1
- MIRIAM HOSPITAL1
- SEATTLE CHILDREN'S HOSPITAL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Impact of Non - B HIV - 1 Subtype on second line Protease Inhibitor Regimens in Africa (INSPIRE)1R01AI147331-01 | NDEMBI, NICAISEQUINONES-MATEU, MIGUEL E | INSTITUTE OF HUMAN VIROLOGY | $581,600 | ZRG1 |
| 2019 | Drug Resistance Genotypic and Phenotypic Correlates of Efavirenz and Dolutegravir based Treatment Outcomes across Non-B HIV-1 subtypes1R01AI147309-01 | DRAIN, PAUL KFRENKEL, LISA MGOTTLIEB, GEOFFREY SCOTT | SEATTLE CHILDREN'S HOSPITAL, WA | $900,704 | ZRG1 |
| 2019 | Addressing HIV drug resistance research gaps in a cohort of perinatally infected Kenyan children and adolescents1R01AI147333-01 | KANTOR, RAMIVREEMAN, RACHEL CHRISTINE | MIRIAM HOSPITAL, RI | $733,086 | ZRG1 |
| 2019 | Novel mechanisms contributing to failure of dolutegravir-containing cART in clinical practice1R01AI147330-01 | BOUCHER, CHARLES ACHIM BERNARD | ERASMUS MEDICAL CENTER | $628,572 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.